Yuhan Corporation (KRX:000100)
South Korea · Delayed Price · Currency is KRW 73,100
-1,900 (-2.53%)
At close: Oct 8, 2026
Yuhan Market Cap
Yuhan has a market cap or net worth of 5.45 trillion as of October 9, 2026. It is the 4,268th most valuable company in the world and the 103rd biggest in South Korea. Its market cap has decreased by 39.19% in one year.
Market Cap
5.45T
Enterprise Value
5.44T
Revenue
2.28T
Global Rank
Country Rank
#103 South Korea
PE Ratio
23.28
ChartMarket Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 5.45T, an increase of 2,253.90%. That is a compound annual growth rate of 13.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 5.45T | -34.99% |
| Dec 30, 2025 | 8.39T | -6.18% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 6.10T |
| Hanall Biopharma | 2.24T |
| Celltrion Pharm | 1.72T |
| GC Biopharma | 1.48T |
| Daewoong Pharmaceutical | 1.25T |
| Chong Kun Dang Pharmaceutical | 868.30B |
| Boryung | 724.33B |
| Daewoong | 659.56B |